Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine

N/ACompletedNCT02983656

Zhejiang Provincial Center for Disease Control and Prevention394 enrolled

Overview

The purpose of this study is to observe the occurrence of adverse events of live attenuated varicella vaccine.

Study Type

OBSERVATIONAL

Enrollment

394

Conditions

Varicocele

Interventions

live attenuated varicella vaccineBIOLOGICAL

Eligibility

Sex: ALLMin age: 1 YearMax age: 15 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The registered permanent residence or resident place are local (reside more than 3 months); * Participant preventive inoculation of varicella vaccine in 2014-2015; * Adverse reactions occurred and should be reported in the AEFI monitoring system. Exclusion Criteria: * Subjects with a known allergy to any ingredient of the vaccine, and with any allergy history to any vaccine; * Subjects with any acute diseases, severe chronic diseases, acute bout of chronic diseases, and catching cold and fever; * Subjects with uncontrolled seizures and other progressive neurological diseases, with a history of Guillain-Barré syndrome.

Outcomes

Primary Outcomes

incidence of adverse reactions

Time frame: 1 year after the first and second doses

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.